Hyperactivity of the hypothalamus-pituitary-adrenal axis in lipopolysaccharide-induced neurodevelopmental model of schizophrenia in rats: Effects of antipsychotic drugs

European Journal of Pharmacology

Volumn 650, Issue 2-3, 2011, Pages 586-595

  Basta Kaim, Agnieszka ^a   Budziszewska, Bogusława ^a   Leśkiewicz, Monika ^a   Fijał, Katarzyna ^a   Regulska, Magdalena ^a   Kubera, Marta ^a   Wȩdzony, Krzysztof ^a   Lasoń, Władysław ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

FKBP51; Glucocorticoid receptor; HPA axis activity; Locomotor activity; Neurodevelopmental model of schizophrenia; Sensorimotor gating

Indexed keywords

CHAPERONE; CHLORPROMAZINE; CLOZAPINE; CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; IMMUNOPHILIN; LIPOPOLYSACCHARIDE; PROTEIN FKBP51; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG EFFECT; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HYPERACTIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOCOMOTION; MALE; NERVE CELL DIFFERENTIATION; NEUROENDOCRINE DISEASE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SCHIZOPHRENIA;

AMPHETAMINE; ANIMALS; ANTIPSYCHOTIC AGENTS; CHLORPROMAZINE; CLOZAPINE; CORTICOSTERONE; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIPOPOLYSACCHARIDES; MALE; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; MOTOR ACTIVITY; PITUITARY-ADRENAL SYSTEM; PREGNANCY; RATS; RATS, WISTAR; RECEPTORS, GLUCOCORTICOID; SCHIZOPHRENIA; STARTLE REACTION; TACROLIMUS BINDING PROTEINS;

EID: 78651090515     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.09.083     Document Type: Article

References (52)

1. A. Barbazanges, P.V. Piazza, M. Le Moal, and S. Maccari Maternal glucocorticoid secretion mediates long-term effects of prenatal stress J. Neurosci. 16 1996 3943 3949
2. A. Basta-Kaim, B. Budziszewska, L. Jaworska-Feil, M. Tetich, M. Leśkiewicz, M. Kubera, and W. Lasoń Chlorpromazine inhibits the glucocorticoid receptor-mediated gene transcription in a calcium-dependent manner Neuropharmacology 43 2002 1035 1043
3. A. Basta-Kaim, B. Budziszewska, L. Jaworska-Feil, M. Tetich, M. Kubera, A. Zajicova, V. Holan, and W. Lasoń Effects of lipopolysaccharide and chlorpromazine on glucocorticoid receptor-mediated gene transcription and immunoreactivity: a possible involvement of p38-MAP kinase Eur. Neuropsychopharmacol. 14 2004 521 528
4. R. Bertini, M. Mengozzi, M. Bianchi, J.D. Sipe, and P. Ghezzi Chlorpromazine protection against interleukin-1 and tumor necrosis factor-mediated activities in vivo Int. J. Immunopharmacol. 13 1991 1085 1090
5. E.B. Binder, D. Salyakina, P. Lichtner, G.M. Wochnik, M. Ising, B. Pütz, S. Papiol, and S. Seaman Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment Nat. Genet. 36 2004 1319 1325
6. J. Borrell, J.M. Vela, A. Arévalo-Martin, E. Molina-Holgado, and C. Guaza Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia Neuropsychopharmacology 26 2002 204 215
7. M.Y. Chan, and W.N. Holmes The effect of some centrally active drugs on corticosterone secretion and metabolism in rats Clin. Exp. Pharmacol. Physiol. 5 1978 641 647
8. K. Chiu, W.M. Lau, K.F. So, and R.C. Chang Microdissection of rat brain for RNA or protein extraction from specific brain region J. Vis. Exp. 7 2007 269 281
9. D. Cotter, and C.M. Pariante Stress and the progression of the developmental hypothesis of schizophrenia Br. J. Psychiatry 181 2002 363 365
10. T.H. Davies, Y.M. Ning, and E.R. Sánchez A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins J. Biol. Chem. 277 2002 4597 4600
11. J.M. Deminiere, P.V. Piazza, G. Guegan, N. Abrous, S. Maccari, M. Le Moal, and H. Simon Increased locomotor response to novelty and propensity to intravenous amphetamine self-administration in adult offspring of stressed mothers Brain Res. 586 1992 135 139
12. D. Diorio, V. Viau, and M.J. Meaney The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress J. Neurosci. 13 1993 3839 3847
13. M.E. Fortier, R. Joober, G.N. Luheshi, and P. Boksa Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring J. Psychiatr. Res. 38 2004 335 345
14. M.E. Fortier, G.N. Luheshi, and P. Boksa Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy Behav. Brain Res. 181 2007 270 277
15. P. Gallagher, S. Watson, M.S. Smith, A.H. Young, and I.N. Ferrier Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder Schizophr. Res. 90 2007 258 265
16. J. Hauser, J. Feldon, and C.R. Pryce Prenatal dexamethasone exposure, postnatal development, and adulthood prepulse inhibition and latent inhibition in Wistar rats Behav. Brain Res. 175 2006 51 61
17. C. Henry, G. Guegant, M. Cador, E. Arnauld, J. Arsaut, M. Le Moal, and J. Demotes-Mainard Prenatal stress in rats facilitates amphetamine-induced sensitization and induces long-lasting changes in dopamine receptors in the nucleus accumbens Brain Res. 685 1995 179 186
18. F. Hung, and M.Y. Chan The effect of long-term chlorpromazine and desipramine treatment on adrenal corticosterone, cyclic AMP, and cholesterol distribution in rats Clin. Exp. Pharmacol. Physiol. 8 1981 567 574
19. R.S. Kahn, L. Siever, M. Davidson, C. Greenwald, and C. Moore Haloperidol and clozapine treatment and their effect on M-chlorophenylpiperazine-mediated responses in schizophrenia: implications for the mechanism of action of clozapine Psychopharmacology 112 1 Suppl 1993 S90 S94
20. A. Kapoor, A. Kostaki, C. Janus, and S.G. Matthews The effects of prenatal stress on learning in adult offspring is dependent on the timing of the stressor Behav. Brain Res. 197 2009 144 149
21. E. Kitraki, D. Karandrea, and C. Kittas Long-lasting effects of stress on glucocorticoid receptor gene expression in the rat brain Neuroendocrinology 69 1999 331 338
22. M. Koehl, M. Darnaudery, J. Dulluc, O. Van Reeth, M. Le Moal, and S. Maccari Prenatal stress alters circadian activity of hypothalamo-pituitary- adrenal axis and hippocampal corticosteroid receptors in adult rats of both gender J. Neurobiol. 40 1999 302 315
23. J.I. Koenig, G.I. Elmer, P.D. Shepard, P.R. Lee, C. Mayo, B. Joy, E. Hercher, and D.L. Brady Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia Behav. Brain Res. 156 2005 251 261
24. M.D. Krstic, I. Rogatsky, K.R. Yamamoto, and M.J. Garabedian Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor Mol. Cell. Biol. 17 1997 3947 3954
25. S.V. Kyosseva, A.D. Elbein, W.S. Griffin, R.E. Mrak, M. Lyon, and C.N. Karson Mitogen-activated protein kinases in schizophrenia Biol. Psychiatry 46 1999 689 696
26. C.H. Lammers, D. Garcia-Borreguero, J. Schmider, U. Gotthardt, M. Dettling, F. Holsboer, and I.J. Heuser Combined dexamethasone/corticotropin- releasing hormone test in patients with schizophrenia and in normal controls: II Biol. Psychiatry 40 1996 560 561
27. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
28. E.J. Marco, O.M. Wolkowitz, S. Vinogradov, J.H. Poole, J. Lichtmacher, and V.I. Reus Double-blind antiglucocorticoid treatment in schizophrenia and schizoaffective disorder: a pilot study World J. Biol. Psychiatry 3 2002 156 161
29. S.G. Matthews Antenatal glucocorticoids and programming of the developing CNS Pediatr. Res. 47 2000 291 300
30. U. Meyer, and J. Feldon Neural basis of psychosis-related behaviour in the infection model of schizophrenia Behav. Brain Res. 204 2009 322 334
31. K. Mizoguchi, A. Ishige, M. Aburada, and T. Tabira Chronic stress attenuates glucocorticoid negative feedback: involvement of the prefrontal cortex and hippocampus Neuroscience 119 2003 887 897
32. J.W. Newcomer, S. Craft, K. Askins, T. Hershey, M.E. Bardgett, J.G. Csernansky, A.E. Gagliardi, and G. Vogler Glucocorticoid interactions with memory function in schizophrenia Psychoneuroendocrinology 23 1998 65 72
33. P.V. Piazza, M. Barrot, F. Rouge-Pont, M. Marinelli, S. Maccari, D.N. Abrous, H. Simon, and M. Le Moal Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission Proc. Natl Acad. Sci. USA 93 1996 15445 15450
34. J.M. Reul, I. Stec, G.J. Wiegers, M.S. Labeur, A.C. Linthorst, E. Arzt, and F. Holsboer Prenatal immune challenge alters the hypothalamic-pituitary- adrenocortical axis in adult rats J. Clin. Invest. 93 1994 2600 2607
35. E. Romero, C. Guaza, B. Castellano, and J. Borrell Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia Mol. Psychiatry 2008 1 12
36. M.C. Ryan, P. Collins, and J.H. Thakore Impaired fasting glucose tolerance in first-episode, drug-naïve patients with schizophrenia Am. J. Psychiatry 160 2003 284 289
37. M.C. Ryan, S. Flanagan, U. Kinsella, F. Keeling, and J.H. Thakore The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia Life Sci. 74 2004 1999 2008
38. R. Sapolsky, C. Rivier, G. Yamamoto, P. Plotsky, and W. Vale Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor Science 238 1987 522 524 (Pubitemid 17147036)
39. U. Shalev, and I. Weiner Gender-dependent differences in latent inhibition following prenatal stress and corticosterone administration Behav. Brain Res. 126 2001 57 63
40. J.E. Swatton, L.A. Sellers, R.L. Faull, A. Holland, S. Iritani, and S. Bahn Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain Eur. J. Neurosci. 19 2004 2711 2719
41. C.G. Sweep, C.J. Boersma, and V.M. Wiegant Effects of chronic treatment with haloperidol and bromocriptine on the processing of beta-endorphin to gamma- and alpha-endorphin in discrete regions of the rat pituitary gland and brain Neuropharmacology 29 1990 61 68
42. M. Szymańska, B. Budziszewska, L. Jaworska-Feil, A. Basta-Kaim, M. Kubera, M. Leśkiewicz, M. Regulska, and W. Lasoń The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats Psychoneuroendocrinology 34 2009 822 832
43. M. Szymańska, A. Suska, B. Budziszewska, L. Jaworska-Feil, A. Basta-Kaim, M. Leśkiewicz, M. Kubera, A. Gergont, S. Kroczka, M. Kaciński, and W. Lasoń Prenatal stress decreases glycogen synthase kinase-3 phosphorylation in the rat frontal cortex Pharmacol. Rep. 61 2009 612 620
44. E.T. Tatro, I.P. Everall, M. Kaul, and C.L. Achim Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder Brain Res. 1286 2009 1 12
45. F.J. Tilders, R.H. DeRijk, A.M. Van Dam, V.A. Vincent, K. Schotanus, and J.H. Persoons Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: routes and intermediate signals Psychoneuroendocrinology 19 1994 209 232
46. A.V. Turnbull, and C.L. Rivier Regulation of the hypothalamic-pituitary- adrenal axis by cytokines: actions and mechanisms of action Physiol. Rev. 79 1999 1 71
47. M.J. Webster, M.B. Knable, J. O'Grady, J. Orthmann, and C.S. Weickert Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders Mol. Psychiatry 7 2002 985 994
48. K. Wȩdzony, M. Maćkowiak, W. Zaja̧czkowski, K. Fijał, A. Chocyk, and A. Czyrak WAY 100135, an antagonist of 5-HT1A serotonin receptors, attenuates psychotomimetic effects of MK-801 Neuropsychopharmacology 23 2000 547 559
49. K. Wȩdzony, K. Fijał, M. Maćkowiak, A. Chocyk, and W. Zaja̧czkowski Impact of postnatal blockade of N-methyl-d-aspartate receptors on rat behavior: a search for a new developmental model of schizophrenia Neuroscience 60 2008 856 864
50. K. Wȩdzony, K. Markowicz-Kula, A. Chocyk, K. Fijał, A. Przyborowska, and M. Mackowiek Impact of postnatal dexamethasone on psychotomimetic effects of MK801 measured on adult rats Pharmacol. Rep. 61 2009 1034 1041
51. V.K. Yeragani The incidence of abnormal dexamethasone suppression in schizophrenia: a review and a meta-analytic comparison with the incidence in normal controls Can. J. Psychiatry 35 1990 128 132
52. R. Zhou, N.A. Gray, P. Yuan, X. Li, J. Chen, G. Chen, P. Damschroder-Williams, J. Du, L. Zhang, and H.K. Manji The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers J. Neurosci. 25 2005 4493 4502